Emerging at the UK, retatrutide, a new compound , is creating considerable buzz within the medical community regarding its ability for weight management . This dual GIP and GLP-1 agent agonist looks to provide a substantial benefit over current therapies, showing positive results in initial clinical studies . Researchers suggest its distinctive mec